272 related articles for article (PubMed ID: 33332718)
1. Salvianolate ameliorates oxidative stress and podocyte injury through modulation of NOX4 activity in db/db mice.
Liang Y; Liu H; Fang Y; Lin P; Lu Z; Zhang P; Jiao X; Teng J; Ding X; Dai Y
J Cell Mol Med; 2021 Jan; 25(2):1012-1023. PubMed ID: 33332718
[TBL] [Abstract][Full Text] [Related]
2. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
[TBL] [Abstract][Full Text] [Related]
3. mTORC2 Signaling Regulates Nox4-Induced Podocyte Depletion in Diabetes.
Eid S; Boutary S; Braych K; Sabra R; Massaad C; Hamdy A; Rashid A; Moodad S; Block K; Gorin Y; Abboud HE; Eid AA
Antioxid Redox Signal; 2016 Nov; 25(13):703-719. PubMed ID: 27393154
[TBL] [Abstract][Full Text] [Related]
4. Mammalian target of rapamycin regulates Nox4-mediated podocyte depletion in diabetic renal injury.
Eid AA; Ford BM; Bhandary B; de Cassia Cavaglieri R; Block K; Barnes JL; Gorin Y; Choudhury GG; Abboud HE
Diabetes; 2013 Aug; 62(8):2935-47. PubMed ID: 23557706
[TBL] [Abstract][Full Text] [Related]
5. The antioxidant silybin prevents high glucose-induced oxidative stress and podocyte injury in vitro and in vivo.
Khazim K; Gorin Y; Cavaglieri RC; Abboud HE; Fanti P
Am J Physiol Renal Physiol; 2013 Sep; 305(5):F691-700. PubMed ID: 23804455
[TBL] [Abstract][Full Text] [Related]
6. Puerarin attenuates diabetic kidney injury through the suppression of NOX4 expression in podocytes.
Li X; Cai W; Lee K; Liu B; Deng Y; Chen Y; Zhang X; He JC; Zhong Y
Sci Rep; 2017 Nov; 7(1):14603. PubMed ID: 29097815
[TBL] [Abstract][Full Text] [Related]
7. Targeting NADPH oxidase with a novel dual Nox1/Nox4 inhibitor attenuates renal pathology in type 1 diabetes.
Gorin Y; Cavaglieri RC; Khazim K; Lee DY; Bruno F; Thakur S; Fanti P; Szyndralewiez C; Barnes JL; Block K; Abboud HE
Am J Physiol Renal Physiol; 2015 Jun; 308(11):F1276-87. PubMed ID: 25656366
[TBL] [Abstract][Full Text] [Related]
8. Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy.
Sedeek M; Callera G; Montezano A; Gutsol A; Heitz F; Szyndralewiez C; Page P; Kennedy CR; Burns KD; Touyz RM; Hébert RL
Am J Physiol Renal Physiol; 2010 Dec; 299(6):F1348-58. PubMed ID: 20630933
[TBL] [Abstract][Full Text] [Related]
9. High glucose provokes microvesicles generation from glomerular podocytes via NOX4/ROS pathway.
Li M; Zhang T; Wu X; Chen Y; Sun L
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31664454
[TBL] [Abstract][Full Text] [Related]
10. AMP-activated protein kinase (AMPK) negatively regulates Nox4-dependent activation of p53 and epithelial cell apoptosis in diabetes.
Eid AA; Ford BM; Block K; Kasinath BS; Gorin Y; Ghosh-Choudhury G; Barnes JL; Abboud HE
J Biol Chem; 2010 Nov; 285(48):37503-12. PubMed ID: 20861022
[TBL] [Abstract][Full Text] [Related]
11. Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy.
Jha JC; Gray SP; Barit D; Okabe J; El-Osta A; Namikoshi T; Thallas-Bonke V; Wingler K; Szyndralewiez C; Heitz F; Touyz RM; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
J Am Soc Nephrol; 2014 Jun; 25(6):1237-54. PubMed ID: 24511132
[TBL] [Abstract][Full Text] [Related]
12. A NOX4/TRPC6 Pathway in Podocyte Calcium Regulation and Renal Damage in Diabetic Kidney Disease.
Ilatovskaya DV; Blass G; Palygin O; Levchenko V; Pavlov TS; Grzybowski MN; Winsor K; Shuyskiy LS; Geurts AM; Cowley AW; Birnbaumer L; Staruschenko A
J Am Soc Nephrol; 2018 Jul; 29(7):1917-1927. PubMed ID: 29793963
[No Abstract] [Full Text] [Related]
13. miR-423-5p suppresses high-glucose-induced podocyte injury by targeting Nox4.
Xu Y; Zhang J; Fan L; He X
Biochem Biophys Res Commun; 2018 Oct; 505(2):339-345. PubMed ID: 30245133
[TBL] [Abstract][Full Text] [Related]
14. NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice.
Zhang L; Li R; Shi W; Liang X; Liu S; Ye Z; Yu C; Chen Y; Zhang B; Wang W; Lai Y; Ma J; Li Z; Tan X
Br J Pharmacol; 2013 Sep; 170(2):426-39. PubMed ID: 23826864
[TBL] [Abstract][Full Text] [Related]
15. Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPARγ-Klotho-FoxO1 axis in diabetic nephropathy.
Xing L; Fang J; Zhu B; Wang L; Chen J; Wang Y; Huang J; Wang H; Yao X
Life Sci; 2021 Mar; 269():119068. PubMed ID: 33476631
[TBL] [Abstract][Full Text] [Related]
16. Smad3/Nox4-mediated mitochondrial dysfunction plays a crucial role in puromycin aminonucleoside-induced podocyte damage.
Yu L; Liu Y; Wu Y; Liu Q; Feng J; Gu X; Xiong Y; Fan Q; Ye J
Cell Signal; 2014 Dec; 26(12):2979-91. PubMed ID: 25229402
[TBL] [Abstract][Full Text] [Related]
17. Swiprosin-1 Promotes Mitochondria-Dependent Apoptosis of Glomerular Podocytes via P38 MAPK Pathway in Early-Stage Diabetic Nephropathy.
Wang RM; Wang ZB; Wang Y; Liu WY; Li Y; Tong LC; Zhang S; Su DF; Cao YB; Li L; Zhang LC
Cell Physiol Biochem; 2018; 45(3):899-916. PubMed ID: 29421811
[TBL] [Abstract][Full Text] [Related]
18. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
Susztak K; Raff AC; Schiffer M; Böttinger EP
Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
[TBL] [Abstract][Full Text] [Related]
19. High glucose induces Nox4 expression and podocyte apoptosis through the Smad3/ezrin/PKA pathway.
Guo W; Gao H; Pan W; Yu P; Che G
Biol Open; 2021 May; 10(5):. PubMed ID: 33046439
[TBL] [Abstract][Full Text] [Related]
20. Beneficial Effect of Chloroquine and Amodiaquine on Type 1 Diabetic Tubulopathy by Attenuating Mitochondrial Nox4 and Endoplasmic Reticulum Stress.
Kang JM; Lee HS; Kim J; Yang DH; Jeong HY; Lee YH; Kim DJ; Park SH; Sung M; Kim J; An HJ; Lee SH; Lee SY
J Korean Med Sci; 2020 Sep; 35(36):e305. PubMed ID: 32924342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]